Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Bibliografski detalji
Glavni autori:	Sebastian, S, Lambe, T
Format:	Journal article
Izdano:	MDPI 2018

Slični predmeti

Clinical Advances in Viral-Vectored Influenza Vaccines
od: Sarah Sebastian, i dr.
Izdano: (2018-05-01)

Viral vector vaccines
od: McCann, N, i dr.
Izdano: (2022)

Clinical development of viral vectored vaccines against MERS-COV
od: Ewer, K, i dr.
Izdano: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
od: D. A. Mezhenskaia, i dr.
Izdano: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
od: Bissett, C, i dr.
Izdano: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
od: Ewer (nee Russell), K, i dr.
Izdano: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
od: Cameron Bissett, i dr.
Izdano: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
od: Arunkumar, G, i dr.
Izdano: (2019)

Research advances in replication-deficient viral vector vaccines
od: Junna Wang, i dr.
Izdano: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
od: McMahon, M, i dr.
Izdano: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
od: Antrobus, R
Izdano: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
od: Tully, C, i dr.
Izdano: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
od: Tully, C
Izdano: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
od: Mullin, J, i dr.
Izdano: (2014)

Development of viral vectors for passive immunisation against influenza
od: Tan, TK
Izdano: (2017)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
od: Irina Isakova-Sivak, i dr.
Izdano: (2022-07-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
od: Marta Ulaszewska, i dr.
Izdano: (2023-01-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
od: Antrobus, R, i dr.
Izdano: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
od: Antrobus, R, i dr.
Izdano: (2014)

Adenoviral vectors as novel vaccines for influenza.
od: Coughlan, L, i dr.
Izdano: (2015)

Viral vectors for malaria vaccine development.
od: Li, S, i dr.
Izdano: (2007)

The use of viral vectors in vaccine development
od: Tatianna Travieso, i dr.
Izdano: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
od: Kenneth Lundstrom
Izdano: (2016-11-01)

Developments in Viral Vector-Based Vaccines
od: Takehiro Ura, i dr.
Izdano: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
od: Ewer (nee Russell), K, i dr.
Izdano: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
od: Kapulu, MC
Izdano: (2014)

Recombinant influenza A viruses as vaccine vectors
od: Thomas Gerlach, i dr.
Izdano: (2019-04-01)

Viral vectors as vaccine platforms: Deployment in sight
od: Rollier, C, i dr.
Izdano: (2011)

Novel viral vector vaccines for tropical infections
od: Rampling, T
Izdano: (2017)

Viral vectors as vaccine platforms: deployment in sight.
od: Rollier, C, i dr.
Izdano: (2011)

Viral Vectors for COVID-19 Vaccine Development
od: Kenneth Lundstrom
Izdano: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
od: Luis Jiménez-Cabello, i dr.
Izdano: (2020-12-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
od: Katie Ewer, i dr.
Izdano: (2017-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
od: Sushmita Kumari, i dr.
Izdano: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
od: Jianfeng Zhang
Izdano: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
od: Shintaro Shichinohe, i dr.
Izdano: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
od: L. M. Khantimirova, i dr.
Izdano: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
od: McAuliffe, J
Izdano: (2020)

Baculovirus expression vector system for production of viral vaccines /
od: 300419 Vlak, J. M., i dr.

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
od: Dulce Mata-Espinosa, i dr.
Izdano: (2023-10-01)